Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

Directorship Changes

6 Sep 2023 08:13

RNS Number : 5523L
East Imperial PLC
06 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

6 September 2023

East Imperial plc

 

(the "Company")

 

 Directorship Changes

 

East Imperial plc, the global purveyor of ultra-premium beverages, today announces that Colin Henry and Toby Hayward will step down as Non-Executive Directors of the Company, effective 1 September 2023.

 

Horace Ngai will join as a Non-Executive Director effective 5 September 2023, appointed to the Company's strategic advisory board in October 2021. Horace began his career at Procter and Gamble in China (1991-2000), during which he was one of the first marketing pioneers for the company, building the success of its haircare & beauty care brands. Between 2000 and 2018, he held various senior management positions at Pernod Ricard across Asia, including Senior President of Pernod Ricard in China.Horace was also the CEO of Sichuan Shui Jing Fang Co. Ltd, a listed company on the Shanghai Stock Exchange majority-owned by Diageo, between 2019 and 2020. Horace is a representative of INL Investments, a distributor of East Imperial products and a recent investor in the Company.

 

Alistair McGeorge will remain as Chair until a suitable replacement with the appropriate industry expertise can be found. Alistair will assume the role of chairing the Audit and Remuneration Committees.

 

 

Alistair McGeorge, Chairman, commented:

 

"I would like to thank Colin and Toby for their contribution to the Board and wish them both well with their next endeavours. The changes to East Imperial reflect a recalibration of the cost structures and the desire for governance support to include an appropriate level of industry expertise. In that regard, I welcome Horace to the board."

 

Tony Burt, CEO/Founder, commented:

 

"I'd like to thank Colin and Toby and wish them all the best for the future. I'd also like to welcome Horace, who brings extensive experience in the premium drinks industry in Asia. His insight and experience will be a huge asset as we work closely with our new investment partner, INL Investments, in that region."

 

Enquiries:

Anthony Burt / Andrew Robertson - investors@eastimperial.com

About East Imperial

Founded in New Zealand and Singapore in 2012, East Imperial produces a range of ultra-premium mixers that sell throughout APAC, the US and EMEA. Guided by a clear strategy to capitalise on the growing demand for premiumisation across the beverage industry, East Imperial has sold over 33 million bottles in over 20 countries since its founding, with popular products including Old World Tonic, Grapefruit Tonic, Yuzu Tonic and Mombasa Ginger Beer. In 2023, East Imperial won 8 medals at the coveted Tonic & Mixers Masters Competition in London. The company was founded on the philosophy of creating exquisite products defined by heritage, tradition and authenticity. All products are made from the highest quality, all-natural ingredients, reflecting East Imperial's commitment to providing a sustainable product and minimising environmental impacts at every stage of the manufacturing process. For more information about East Imperial and its ultra-premium mixers, visit eastimperial.co.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGGLNVLGFZG
Date   Source Headline
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
14th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSInterim results
1st Sep 20227:10 amRNSAppointment of WH Ireland as Joint Broker
12th Aug 20229:05 amRNSSecond Price Monitoring Extn
12th Aug 20229:00 amRNSPrice Monitoring Extension
12th Aug 20227:00 amRNSChina Distribution Agreement
21st Jul 20227:00 amRNSPre-Close Trading Statement
1st Jun 20221:44 pmRNSResult of AGM
27th May 20222:00 pmRNSNotice of AGM: Correction
10th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFull Year Results
29th Apr 202212:40 pmRNSShort Delay to Publication of Annual Report
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20222:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20222:00 pmRNSPrice Monitoring Extension
25th Feb 20228:46 amRNSDirectorship Change
18th Feb 20229:47 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSUS Distribution Agreement
13th Jan 20227:00 amRNSPlacing and year-end update
10th Dec 20215:00 pmRNSDirector/PDMR Shareholding
9th Dec 20219:00 amRNSDirector/PDMR Shareholding
3rd Dec 20212:23 pmRNSDirectorate Changes and Withdrawal of Requisition
17th Nov 20217:00 amRNSRequisition of Extraordinary General Meeting
5th Nov 20217:00 amRNSSingapore Distribution Partner
1st Nov 20217:00 amRNSAppointment of Head of Sales for North America
19th Oct 20217:00 amRNSAppointments to new Strategic Advisory Board
29th Sep 202112:56 pmRNSShareholder Update
13th Sep 20217:00 amRNSTrading Update
13th Sep 20217:00 amRNSBermele Interim Accounts
7th Sep 20214:41 pmRNSSecond Price Monitoring Extn
7th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20212:05 pmRNSSecond Price Monitoring Extn
7th Sep 20212:00 pmRNSPrice Monitoring Extension
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
27th Aug 20219:05 amRNSSecond Price Monitoring Extn
27th Aug 20219:00 amRNSPrice Monitoring Extension
27th Aug 20217:37 amRNSNew Supply Agreements
16th Aug 20212:05 pmRNSSecond Price Monitoring Extn
16th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Aug 20217:00 amRNSSupply Agreement
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:06 pmRNSSecond Price Monitoring Extn
27th Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jul 20217:00 amRNSChange of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.